Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rose

Showing results (161-170 of 218) with videos related to

Pageof 22
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2022
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension studyCorey C Ford, Jeffrey A Cohen, Andrew D Goodman, et al.
Neurology|October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the USKristen M Krysko, Jennifer Graves, Mary Rensel, et al.
Journal of Intellectual Disability Research : JIDR|April 21, 2026
The Development and Validation of Models of Risk for Behaviours That Challenge in Children With Developmental Disabilities: A Novel Machine Learning ApproachLaura Groves, Guy Davies, Chris Oliver, et al.
World Journal of Surgery|August 10, 2022
Prevalence and Severity of Burn Scars in Rural MozambiquePatrick Barba, Daniel C Neubauer, Matchecane Cossa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2023
Neurologic Manifestations of Common Variable Immunodeficiency: Impact on Quality of LifeBruno Ivo De Almeida, Tammy L Smith, Alen Delic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survivalLiam Cornell, Joanne M Munck, Clara Alsinet, et al.
BMJ Open|December 17, 2025
A multicentred two-arm parallel single-blind superiority randomised controlled trial comparing psychological and emotional stabilisation with eye movement desensitisation and reprocessing and treatment-as-usual to treatment-as-usual with adults with intellectual disabilities who have post-traumatic stress disorder (the Trauma-AID trial): protocolPaul Willner, Pippa Anderson, Jonathan I Bisson, et al.
Multiple Sclerosis and Related Disorders|March 15, 2025
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseaseRebecca MacRae, Jonathan Race, Allison Schuette, et al.
Multiple Sclerosis and Related Disorders|June 5, 2024
Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumabZahra Nasr, T Charles Casper, Michael Waltz, et al.
The Lancet. Neurology|February 3, 2009
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II studyRichard K Burt, Yvonne Loh, Bruce Cohen, et al.
Pageof 22

Showing results (161-170 of 218) with videos related to

Sort By:
Pageof 22
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2022
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension studyCorey C Ford, Jeffrey A Cohen, Andrew D Goodman, et al.
Neurology|October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the USKristen M Krysko, Jennifer Graves, Mary Rensel, et al.
Journal of Intellectual Disability Research : JIDR|April 21, 2026
The Development and Validation of Models of Risk for Behaviours That Challenge in Children With Developmental Disabilities: A Novel Machine Learning ApproachLaura Groves, Guy Davies, Chris Oliver, et al.
World Journal of Surgery|August 10, 2022
Prevalence and Severity of Burn Scars in Rural MozambiquePatrick Barba, Daniel C Neubauer, Matchecane Cossa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2023
Neurologic Manifestations of Common Variable Immunodeficiency: Impact on Quality of LifeBruno Ivo De Almeida, Tammy L Smith, Alen Delic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survivalLiam Cornell, Joanne M Munck, Clara Alsinet, et al.
BMJ Open|December 17, 2025
A multicentred two-arm parallel single-blind superiority randomised controlled trial comparing psychological and emotional stabilisation with eye movement desensitisation and reprocessing and treatment-as-usual to treatment-as-usual with adults with intellectual disabilities who have post-traumatic stress disorder (the Trauma-AID trial): protocolPaul Willner, Pippa Anderson, Jonathan I Bisson, et al.
Multiple Sclerosis and Related Disorders|March 15, 2025
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseaseRebecca MacRae, Jonathan Race, Allison Schuette, et al.
Multiple Sclerosis and Related Disorders|June 5, 2024
Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumabZahra Nasr, T Charles Casper, Michael Waltz, et al.
The Lancet. Neurology|February 3, 2009
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II studyRichard K Burt, Yvonne Loh, Bruce Cohen, et al.
Pageof 22